Holen Sie sich die Stockscreener-App
1.08
3.57%
-0.04
Vorhandelsmarkt:
1.09
0.01
+0.93%
Schlusskurs vom Vortag:
$1.12
Offen:
$1.13
24-Stunden-Volumen:
140.06K
Relative Volume:
0.23
Marktkapitalisierung:
$28.05M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-10.21M
KGV:
-1.8487
EPS:
-0.5842
Netto-Cashflow:
-
1W Leistung:
-5.26%
1M Leistung:
-13.60%
6M Leistung:
+4.85%
1J Leistung:
-14.95%
1-Tages-Spanne:
$1.07
$1.1383
1-Wochen-Bereich:
$1.03
$1.16
52-Wochen-Spanne:
$0.80
$2.60
Neurosense Therapeutics Ltd Stock (NRSN) Company Profile
Firmenname
Neurosense Therapeutics Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie NRSN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRSN
Neurosense Therapeutics Ltd
|
1.08 | 28.05M | 0 | -10.21M | 0 | -0.5842 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Neurosense Therapeutics Ltd Aktie (NRSN) Neueste Nachrichten
Will NeuroSense Therapeutics Ltd. Equity Warrant stock sustain high P E ratios2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com
Will NeuroSense Therapeutics Ltd. Equity Warrant stock attract more institutional investorsJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
What momentum indicators show for NeuroSense Therapeutics Ltd. stockWeekly Trade Report & AI Forecasted Entry and Exit Points - newser.com
Tick level data insight on NeuroSense Therapeutics Ltd. Equity Warrant volatilityMarket Volume Report & Fast Exit/Entry Strategy Plans - newser.com
Detecting support and resistance levels for NeuroSense Therapeutics Ltd. Equity Warrant2025 Historical Comparison & Growth Focused Investment Plans - newser.com
How to use a screener to detect NeuroSense Therapeutics Ltd. Equity Warrant breakoutsWeekly Risk Summary & Reliable Intraday Trade Alerts - newser.com
Key metrics from NeuroSense Therapeutics Ltd. Equity Warrant’s quarterly dataMarket Sentiment Review & Risk Adjusted Buy/Sell Alerts - newser.com
Real time scanner hits for NeuroSense Therapeutics Ltd. Equity Warrant explained2025 Volatility Report & Risk Managed Investment Signals - newser.com
Will NeuroSense Therapeutics Ltd. (H1Z) stock outperform value peers2025 Market Overview & Trade Opportunity Analysis - newser.com
NeuroSense to Host Investor Webinar on December 8, 2025 - The Malaysian Reserve
NeuroSense (NASDAQ: NRSN) sets Dec. 8, 2025 investor webinar on ALS PARAGON, Canada NOC/c - Stock Titan
Analyzing NeuroSense Therapeutics Ltd. Equity Warrant with multi timeframe chartsIPO Watch & Reliable Breakout Forecasts - newser.com
How moving averages guide NeuroSense Therapeutics Ltd. Equity Warrant tradingTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com
Can volume confirm reversal in NeuroSense Therapeutics Ltd.Earnings Risk Report & AI Driven Stock Reports - newser.com
Tools to monitor NeuroSense Therapeutics Ltd. recovery probabilityTrade Exit Summary & Real-Time Stock Entry Alerts - newser.com
Using Ichimoku Cloud for NeuroSense Therapeutics Ltd. Equity Warrant technicalsProfit Target & Consistent Return Investment Signals - newser.com
Historical volatility pattern of NeuroSense Therapeutics Ltd. Equity Warrant visualizedQuarterly Earnings Report & Risk Managed Investment Strategies - newser.com
How institutional ownership impacts NeuroSense Therapeutics Ltd. stockJuly 2025 Short Interest & Capital Efficiency Focused Strategies - newser.com
What downside risks could hit NeuroSense Therapeutics Ltd. (H1Z) stockMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
Signal strength of NeuroSense Therapeutics Ltd. stock in tech scannersVolume Spike & Weekly Watchlist of Top Performers - newser.com
Key metrics from NeuroSense Therapeutics Ltd.’s quarterly data2025 Retail Activity & Long-Term Safe Investment Plans - newser.com
Is NeuroSense Therapeutics Ltd. stock a safe haven assetJuly 2025 Trends & Low Risk Growth Stock Ideas - newser.com
Can NeuroSense Therapeutics Ltd. hit a new high this month2025 Short Interest & Long-Term Growth Portfolio Plans - newser.com
Using R and stats models for NeuroSense Therapeutics Ltd. Equity Warrant forecastingQuarterly Market Summary & Technical Pattern Recognition Alerts - newser.com
Visual analytics tools that track NeuroSense Therapeutics Ltd. performanceQuarterly Growth Report & Verified Swing Trading Watchlist - newser.com
Tools to monitor NeuroSense Therapeutics Ltd. Equity Warrant recovery probability2025 Pullback Review & AI Driven Stock Reports - newser.com
Multi factor analysis applied to NeuroSense Therapeutics Ltd. Equity WarrantJuly 2025 Institutional & Safe Investment Capital Preservation Plans - newser.com
How NeuroSense Therapeutics Ltd. Equity Warrant stock performs in stagflation2025 Retail Activity & Real-Time Price Movement Reports - newser.com
Using RSI to spot recovery in NeuroSense Therapeutics Ltd.Weekly Market Summary & Expert-Curated Trade Recommendations - newser.com
Visualizing NeuroSense Therapeutics Ltd. stock with heatmapsJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
Using data tools to time your NeuroSense Therapeutics Ltd. Equity Warrant exitJuly 2025 Breakouts & Weekly Watchlist of Top Performers - newser.com
Is NeuroSense Therapeutics Ltd. showing signs of accumulation2025 Analyst Calls & Safe Entry Point Alerts - newser.com
Finanzdaten der Neurosense Therapeutics Ltd-Aktie (NRSN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):